AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
The night the tip jar went missing, we assumed that it had been stolen by a student, or maybe a professor—an adjunct—who had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results